The 2023 Institute for Glycomics Grand Ball was held on Saturday 7 October at RACV Royal Pines Resort. The glamorous...
Griffith University is bidding a grateful farewell to community champion and Director of the Institute for Glycomics, Professor Mark von...
Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.
Institute for Glycomics researchers receive funding boost in their fight against cancer with $2.6 million awarded by the Australian Cancer Research Foundation.
The Institute for Glycomics 21st Birthday Grand Ball presented by Meriton Group will be held on Saturday 14 August at...
Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical...
Australian and German researchers from the international consortium iCAIR® (Fraunhofer International Consortium for Anti-Infective Research), comprising of Griffith University’s Institute...
Some of Griffith University’s most outstanding researchers have been honoured at the Institute for Glycomics Research Excellence Awards evening. Attended...
Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
